bimekizumab
ucb pharmaceuticals
['bimekizumab']
3 new drugs licensed since 2019 update bimekizumab pending authorization (dual il17a &amp; f inhibition) + more data on long term efficacy &amp; safety data (esp for jakibs) #eular2023
@bu_bmc_rheum | @rheum_covid @spartan_updates @official_asas | @UWRheum @UWEpidemiology 2020 | @OHSUIMres 2017 | @UTMBhealth 2014 | @UTAustin 2010